| Patent | Date |
|---|
Mesenchymal stem cells for the treatment of CNS diseases
Grant 11,185,572 - Kadouri , et al. November 30, 2 | 2021-11-30 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 10,869,899 - Offen , et al. December 22, 2 | 2020-12-22 |
Genetically modified muscle cells which express neurotrophic factors
Grant 10,744,162 - Offen , et al. A | 2020-08-18 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20190201452 - OFFEN; Daniel ; et al. | 2019-07-04 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20180333458 - KADOURI; Avinoam ; et al. | 2018-11-22 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 10,052,363 - Kadouri , et al. August 21, 2 | 2018-08-21 |
Isolated Cells And Populations Comprising Same For The Treatment Of Cns Diseases
App 20180112185 - OFFEN; Daniel ; et al. | 2018-04-26 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 9,879,225 - Offen , et al. January 30, 2 | 2018-01-30 |
Stem cell-derived neural cells for cell therapy in neurological disorders
Grant 9,717,761 - Pitaru , et al. August 1, 2 | 2017-08-01 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20160375098 - KADOURI; Avinoam ; et al. | 2016-12-29 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 9,474,787 - Kadouri , et al. October 25, 2 | 2016-10-25 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20160279169 - OFFEN; Daniel ; et al. | 2016-09-29 |
Genetically modified muscle cells which express neurotrophic factors
Grant 9,365,828 - Offen , et al. June 14, 2 | 2016-06-14 |
Peptides for the treatment of oxidative stress related disorders
Grant 9,023,800 - Offen , et al. May 5, 2 | 2015-05-05 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20150086517 - Kadouri; Avinoam ; et al. | 2015-03-26 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 8,900,574 - Kadouri , et al. December 2, 2 | 2014-12-02 |
Stem Cell-derived Neural Cells For Cell Therapy In Neurological Disorders
App 20140335059 - Pitaru; Sandu ; et al. | 2014-11-13 |
Isolated Cells And Populations Comprising Same For The Treatment Of Cns Diseases
App 20140154222 - OFFEN; Daniel ; et al. | 2014-06-05 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20140140968 - KADOURI; Avinoam ; et al. | 2014-05-22 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 8,663,987 - Kadouri , et al. March 4, 2 | 2014-03-04 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 8,647,874 - Offen , et al. February 11, 2 | 2014-02-11 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20130344041 - Offen; Daniel ; et al. | 2013-12-26 |
Methods, Nucleic Acid Constructs And Cells For Treating Neurodegenerative Disorders
App 20130236964 - MELAMED; Eldad ; et al. | 2013-09-12 |
Peptides For The Regulation Of Neurotransmitter Sequestration And Release
App 20130123187 - LEV; Nirit ; et al. | 2013-05-16 |
Peptides for the regulation of neurotransmitter sequestration and release
Grant 8,378,070 - Lev , et al. February 19, 2 | 2013-02-19 |
Peptides For The Treatment Of Oxidative Stress Related Disorders
App 20120225822 - OFFEN; Daniel ; et al. | 2012-09-06 |
Peptides for the treatment of oxidative stress related disorders
Grant 8,212,001 - Offen , et al. July 3, 2 | 2012-07-03 |
Method and system for real-time adaptive quantization control
Grant 8,213,502 - Melamed , et al. July 3, 2 | 2012-07-03 |
Peptides For The Treatment Of Oxidative Stress Related Disorders
App 20110212896 - Offen; Daniel ; et al. | 2011-09-01 |
Regulation Of Neurotransmitters Sequestration And Release Through Manipulation Of The Vesicular Functions
App 20100093600 - Lev; Nirit ; et al. | 2010-04-15 |
Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS Diseases
App 20100021434 - Melamed; Eldad ; et al. | 2010-01-28 |
Method of generating dopamine-secreting cells
App 20090257987 - Offen; Daniel ; et al. | 2009-10-15 |
Method And System For Real-time Adaptive Quantization Control
App 20090168869 - MELAMED; Eldad ; et al. | 2009-07-02 |
Isolated cells and populations comprising same for the treatment of CNS diseases
App 20090010895 - Offen; Daniel ; et al. | 2009-01-08 |
Method and apparatus for motion estimation in a sequence of digital images
Grant 7,280,594 - Sadeh , et al. October 9, 2 | 2007-10-09 |
Treatment of multiple sclerosis with brain targeted anti oxidant compounds
App 20060211628 - Atlas; Daphne ; et al. | 2006-09-21 |
Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
App 20050265983 - Melamed, Eldad ; et al. | 2005-12-01 |
Methods of treating and/or preventing autoimmune diseases
App 20040235747 - Gozes, Illana ; et al. | 2004-11-25 |
Method and apparatus for motion estimation in a sequence of digital images
App 20030081675 - Sadeh, Yaron M. ; et al. | 2003-05-01 |
Treatment of ischemic brain injuries with brain targeted antioxidant compounds
App 20030083266 - Atlas, Daphne ; et al. | 2003-05-01 |
Brain targeted low molecular weight hydrophobic anti oxidant compounds
App 20020107176 - Atlas, Daphne ; et al. | 2002-08-08 |
Brain targeted low molecular weight hydrophobic antioxidant compounds
Grant 6,420,429 - Atlas , et al. July 16, 2 | 2002-07-16 |
Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
Grant 6,369,106 - Atlas , et al. April 9, 2 | 2002-04-09 |
Brain targeted low molecular weight hydrophobic antioxidant compounds
Grant 5,874,468 - Atlas , et al. February 23, 1 | 1999-02-23 |
Pharmaceutical composition of L-DOPA ester
Grant 5,840,756 - Cohen , et al. November 24, 1 | 1998-11-24 |
L-DOPA ethyl ester to treat Parkinson's disease
Grant 5,607,969 - Milman , et al. March 4, 1 | 1997-03-04 |
Compositions of the ethyl ester of L-DOPA
Grant 5,525,631 - Milman , et al. June 11, 1 | 1996-06-11 |
Process for preparing ethyl ester of L-DOPA
Grant 5,354,885 - Milman , et al. October 11, 1 | 1994-10-11 |
| 